Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

  • These materials discuss and/or include the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 Version Date 4/26/2020 (PRO-CTCAE V1.0) which is owned exclusively by the Division of Cancer Control and Population Sciences in the NATIONAL CANCER INSTITUTE at the NATIONAL INSTITUTES OF HEALTH (NCI). No part of the PRO-CTCAE V1.0 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying recording, or other electronic or mechanical methods, without the prior written permission of NCI and payment of any applicable fees. PRO-CTCAE V1.0 copyright, NATIONAL CANCER INSTITUTE at the NATIONAL INSTITUTES OF HEALTH (NCI). All rights reserved.
  • The PRO-CTCAE trademark items and information herein were developed by the Division of Cancer Control and Population Sciences in the NATIONAL CANCER INSTITUTE at the NATIONAL INSTITUTES OF HEALTH, in Bethesda, Maryland, U.S.A. Use of the PRO-CTCAE is subject to NCI's "Terms of Use". PRO-CTCAE Measurement System content should be downloaded using the "Instrument & Form Builder". https://healthcaredelivery.cancer.gov/prot-ctcae/. (Basch E, Reeve BB, Mitchell SA, Clauser SB, Minasian LM, Dueck AC, Mendoza TR, Hay J, Atkinson TM, Abernethy AP, Bruner DW, Cleeland CS, Sloan JA, Chilukuri R, Baumgartner P, Denicoff A, St Germain D, O'Mara AM, Chen A, Kelaghan J, Bennett AV, Sit L, Rogak L, Barz A, Paul DB, Schrag D. Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). J Natl Cancer Inst 2014 Sept 29;106(9)).
  • [1] National Institutes of Health – National Cancer Institute, Division of Cancer Control & Population Sciences. (2017, July 2) https://healthcaredelivery.cancer.gov/pro-ctcae/overview.html

...

  1. As a CDISC QRS standard, the instrument name is PRO-CTCAE V1.0, as provided in this supplement. As an item library, sponsors may select items from the overall library as a subset of items with the same CDISC Controlled Terminology as appropriate for the condition being studied. It is the users responsibility to identify the subset of items used from the overall PRO-CTCAE V1.0 Item Library (Version 1.0). The subsetted PRO-CTCAE V1.0 user's instrument should be titled "PRO-CTCAE sponsor-specified symptoms..." based on the sponsor's discretion when they identify the specific items being used. This will distinctly describe the subsetted instrument from the overall PRO-CTCAE V1.0.
  2. For the PRO-CTCAE V1.0, QSORRES is populated with the text description while the numeric rating is represented in the standardized character and numeric result variables QSSTRESC and QSSTRESN. Please reference the PRO-CTCAE website FAQs for more details on the numeric responsesThe responses for the PRO-CTCAE V1.0 are as follows:

    1. Depending on the symptomatic AE being measured, items assessing symptom presence/absence are rated as follows:
      1. Items rated on a binary response scale and rated from 0-1 (e.g., 0 = “No” and 1 = “Yes”);
      2. Items rated on multiple (more than two) response scale and rated from 0-1 (e.g., 0 = “No”, 1 = “Yes”, and “Not applicable” or "Not Applicable"); or
      3. Items rated on multiple (more than two) response scale and rated from 0-1 (e.g., 0 = “No”, 1 = “Yes”, “Not sexually active”, and “Prefer not to answer”).
    2. Items assessing symptom amount are rated on a 5-point scale and rated from 0-4 (e.g., 0 = “Not at all”, 1 = “A little bit”, 2 = “Somewhat”, 3 = “Quite a bit”, and 4 = “Very much”).
    3. Items assessing symptom frequency are rated on a 5-point scale and are rated from 0-4 (e.g., 0 = “Never”, 1 = “Rarely”, 2 = “Occasionally”, 3 = “Frequently”, and 4 = “Almost constantly”, "Not sexually
      active", and “Prefer not to answer”).
    4. Items assessing symptom severity are rated on a 5-point scale and are rated from 0-4 (e.g., 0 = “None”, 1 = “Mild”, 2 = “Moderate”, 3 = “Severe”, and 4 = “Very severe”, “Not applicable”, "Not sexually
      active", and “Prefer not to answer”).
    5. Items assessing symptom interference are rated on a 5-point scale and are rated from 0-4 (e.g., 0 = “Not at all”, 1 = “A little bit”, 2 = “Somewhat”, 3 = “Quite a bit”, and 4 = “Very much”).
  3. The CRF represents up to 5 "other symptoms" to be recorded. In discussions with NIH, it was agreed to provide up to 10 "other symptoms" to be recorded if they existed. QSTESTCDs (QSTESTCDs "PT01082A" thru "PT0191A") and severity of the symptom at its worst (QSTESTCDs "PT01082B" thru "PT0191B").
  4. Total scoring instructions have not yet been developed. Item-level scores are not combined (i.e., No total score nor symptom-specific scores are calculated.).
  5. The time period of evaluation for the PRO-CTCAE V1.0 is populated in the QSEVLINT field in ISO 8601 format when the evaluation interval can be precisely described as duration. The evaluation interval for the PRO-CTCAE V1.0 is the past 7 days (QSEVLINT = "-P7D". Please reference the PRO-CTCAE website for more details on the evaluation interval.
  6. Items are divided into 14 15 subcategories represented in the QSSCAT variable. These categorizations represent how the symptom terms are categorized in the PRO-CTCAE V1.0 Item Library (Version 1.0). See Section 4, SDTM Mapping Strategy, for a list of these subcategory values. 
    1. The symptomatic AE being measured by a given item (e.g., the Symptom Term represented on the CRF corresponding to a given item) is stored in the SUPPQS dataset with the QNAM = "QSSYMPTM". This matches the symptom term identified in the PRO-CTCAE V1.0 Item Library (Version 1.0). The exception to this is the solicited verbatim symptom terms with QNAM = "OTHER SYMPTOMS".
  7. Electronic conditional branching is recommended by NCI/NIH in the conduct of the PRO-CTCAE V1.0 for symptom terms that have two or more items. The logic branches from frequency, then to severity, then to interference. For example, if frequency is > (greater than) never, you next pose the severity question, and if severity>none, you pose the interference question. Please reference the PRO-CTCAE website for more details on the electronic conditional branching approach. In the conduct of the PRO-CTCAE V1.0 it expects responses for each item and there should be no missing responses. Electronic branched severity items are assigned responses of 0 = "None" and electronic branched interference items are assigned 0 = "Not al all".

  8. The language in which the PRO-CTCAE V1.0 was administered (e.g., English, Spanish, Japanese) is collected with the Form Builder application and may be represented as a supplemental qualifier with QNAM = "QSDCLANG". Reference the PRO-CTCAE V1.0 website for a list of available language translations.
  9. Terminology
    1. QSCAT, QSTESTCD, and QSTEST values are included in CDISC Controlled Terminology.

    2. A full list of value sets for the qualifier, and result fields is provided in Section 4, SDTM Mapping Strategy.

...

Dataset wrap
Nameqs


Rowcaps


Rows 20-21:

Represent the symptom hiccups did not occur and then the symptom of hiccups severity was logically skipped.

Rows 24-26:Represent the symptom abdominal pain frequency did not occur and then the symptoms of abdominal pain severity and abdominal pain interference were logically skipped
Rows 126-129:Represent two additional symptoms that existed for the subject.
Rows 130-145:Represent the symptoms "Other Symptom 3 and Other Symptom 3 Severity" through "Other Symptom 10 and Other Symptom 10 Severity" that did not exist for the subject.



Dataset2


RowSTUDYIDDOMAINUSUBJIDQSSEQQSTESTCDQSTESTQSCATQSSCATQSORRESQSSTRESCQSSTRESNQSLOBXFLVISITNUMQSDTCQSEVLINT
1STUDYXQS23-P00011PT01001APT01-Dry Mouth SeverityPRO-CTCAE V1.0ORALMild11Y12015-05-15-P7D
2STUDYXQS23-P00012PT01002APT01-Difficulty Swallowing SeverityPRO-CTCAE V1.0ORALMild11Y12015-05-15-P7D
3STUDYXQS23-P00013PT01003APT01-Mouth/Throat Sores SeverityPRO-CTCAE V1.0ORALMild11Y12015-05-15-P7D
4STUDYXQS23-P00014PT01003BPT01-Mouth/Throat Sores InterferencePRO-CTCAE V1.0ORALA little bit11Y12015-05-15-P7D
5STUDYXQS23-P00015PT01004APT01-Cracking Corners of Mouth SeverityPRO-CTCAE V1.0ORALMild11Y12015-05-15-P7D
6STUDYXQS23-P00016PT01005APT01-Voice Quality Changes PresencePRO-CTCAE V1.0ORALNo0
Y12015-05-15-P7D
7STUDYXQS23-P00017PT01006APT01-Hoarseness SeverityPRO-CTCAE V1.0ORALMild11Y12015-05-15-P7D
8STUDYXQS23-P00018PT01007APT01-Taste Changes SeverityPRO-CTCAE V1.0GASTROINTESTINALMild11Y12015-05-15-P7D
9STUDYXQS23-P00019PT01008APT01-Decreased Appetite SeverityPRO-CTCAE V1.0GASTROINTESTINALMild11Y12015-05-15-P7D
10STUDYXQS23-P000110PT01008BPT01-Decreased Appetite InterferencePRO-CTCAE V1.0GASTROINTESTINALSomewhat22Y12015-05-15-P7D
11STUDYXQS23-P000111PT01009APT01-Nausea FrequencyPRO-CTCAE V1.0GASTROINTESTINALOccasionally22Y12015-05-15-P7D
12STUDYXQS23-P000112PT01009BPT01-Nausea SeverityPRO-CTCAE V1.0GASTROINTESTINALMild11Y12015-05-15-P7D
13STUDYXQS23-P000113PT01010APT01-Vomiting FrequencyPRO-CTCAE V1.0GASTROINTESTINALOccasionally22Y12015-05-15-P7D
14STUDYXQS23-P000114PT01010BPT01-Vomiting SeverityPRO-CTCAE V1.0GASTROINTESTINALMild11Y12015-05-15-P7D
15STUDYXQS23-P000115PT01011APT01-Heartburn FrequencyPRO-CTCAE V1.0GASTROINTESTINALOccasionally22Y12015-05-15-P7D
16STUDYXQS23-P000116PT01011BPT01-Heartburn SeverityPRO-CTCAE V1.0GASTROINTESTINALMild11Y12015-05-15-P7D
17STUDYXQS23-P000117PT01012APT01-Gas PresencePRO-CTCAE V1.0GASTROINTESTINALNo00Y12015-05-15-P7D
18STUDYXQS23-P000118PT01013APT01-Bloating FrequencyPRO-CTCAE V1.0GASTROINTESTINALOccasionally22Y12015-05-15-P7D
19STUDYXQS23-P000119PT01013BPT01-Bloating SeverityPRO-CTCAE V1.0GASTROINTESTINALMild11Y12015-05-15-P7D
20STUDYXQS23-P000120PT01014APT01-Hiccups FrequencyPRO-CTCAE V1.0GASTROINTESTINALNever00Y12015-05-15-P7D
21STUDYXQS23-P000121PT01014BPT01-Hiccups SeverityPRO-CTCAE V1.0GASTROINTESTINALNone00Y12015-05-15-P7D
22STUDYXQS23-P000122PT01015APT01-Constipation SeverityPRO-CTCAE V1.0GASTROINTESTINALMild11Y12015-05-15-P7D
23STUDYXQS23-P000123PT01016APT01-Diarrhea FrequencyPRO-CTCAE V1.0GASTROINTESTINALRarely11Y12015-05-15-P7D
24STUDYXQS23-P000124PT01017APT01-Abdominal Pain FrequencyPRO-CTCAE V1.0GASTROINTESTINALNever00Y12015-05-15-P7D
25STUDYXQS23-P000125PT01017BPT01-Abdominal Pain SeverityPRO-CTCAE V1.0GASTROINTESTINALNone00Y12015-05-15-P7D
26STUDYXQS23-P000126PT01017CPT01-Abdominal Pain InterferencePRO-CTCAE V1.0GASTROINTESTINALNot at all00Y12015-05-15-P7D
27STUDYXQS23-P000127PT01018APT01-Fecal Incontinence FrequencyPRO-CTCAE V1.0GASTROINTESTINALOccasionally22Y12015-05-15-P7D
28STUDYXQS23-P000128PT01018BPT01-Fecal Incontinence InterferencePRO-CTCAE V1.0GASTROINTESTINALSomewhat22Y12015-05-15-P7D
29STUDYXQS23-P000129PT01019APT01-Shortness of Breath SeverityPRO-CTCAE V1.0RESPIRATORYMild11Y12015-05-15-P7D
30STUDYXQS23-P000130PT01019BPT01-Shortness of Breath InterferencePRO-CTCAE V1.0RESPIRATORYSomewhat22Y12015-05-15-P7D
31STUDYXQS23-P000131PT01020APT01-Cough SeverityPRO-CTCAE V1.0RESPIRATORYMild11Y12015-05-15-P7D
32STUDYXQS23-P000132PT01020BPT01-Cough InterferencePRO-CTCAE V1.0RESPIRATORYSomewhat22Y12015-05-15-P7D
33STUDYXQS23-P000133PT01021APT01-Wheezing SeverityPRO-CTCAE V1.0RESPIRATORYMild11Y12015-05-15-P7D
34STUDYXQS23-P000134PT01022APT01-Swelling FrequencyPRO-CTCAE V1.0CARDIO/CIRCULATORYOccasionally22Y12015-05-15-P7D
35STUDYXQS23-P000135PT01022BPT01-Swelling SeverityPRO-CTCAE V1.0CARDIO/CIRCULATORYMild11Y12015-05-15-P7D
36STUDYXQS23-P000136PT01022CPT01-Swelling InterferencePRO-CTCAE V1.0CARDIO/CIRCULATORYSomewhat22Y12015-05-15-P7D
37STUDYXQS23-P000137PT01023APT01-Heart Palpitations FrequencyPRO-CTCAE V1.0CARDIO/CIRCULATORYOccasionally22Y12015-05-15-P7D
38STUDYXQS23-P000138PT01023BPT01-Heart Palpitations SeverityPRO-CTCAE V1.0CARDIO/CIRCULATORYMild11Y12015-05-15-P7D
39STUDYXQS23-P000139PT01024APT01-Rash PresencePRO-CTCAE V1.0CUTANEOUSNo00Y12015-05-15-P7D
40STUDYXQS23-P000140PT01025APT01-Skin Dryness SeverityPRO-CTCAE V1.0CUTANEOUSMild11Y12015-05-15-P7D
41STUDYXQS23-P000141PT01026APT01-Acne SeverityPRO-CTCAE V1.0CUTANEOUSMild11Y12015-05-15-P7D
42STUDYXQS23-P000142PT01027APT01-Hair Loss AmountPRO-CTCAE V1.0CUTANEOUSQuite a bit33Y12015-05-15-P7D
43STUDYXQS23-P000143PT01028APT01-Itching SeverityPRO-CTCAE V1.0CUTANEOUSMild11Y12015-05-15-P7D
44STUDYXQS23-P000144PT01029APT01-Hives PresencePRO-CTCAE V1.0CUTANEOUSNo00Y12015-05-15-P7D
45STUDYXQS23-P000145PT01030APT01-Hand-Foot Syndrome SeverityPRO-CTCAE V1.0CUTANEOUSMild11Y12015-05-15-P7D
46STUDYXQS23-P000146PT01031APT01-Nail Loss PresencePRO-CTCAE V1.0CUTANEOUSNo00Y12015-05-15-P7D
47STUDYXQS23-P000147PT01032APT01-Nail Ridging PresencePRO-CTCAE V1.0CUTANEOUSNo00Y12015-05-15-P7D
48STUDYXQS23-P000148PT01033APT01-Nail Discoloration PresencePRO-CTCAE V1.0CUTANEOUSNo00Y12015-05-15-P7D
49STUDYXQS23-P000149PT01034APT01-Sensitivity to Sunlight PresencePRO-CTCAE V1.0CUTANEOUSNo00Y12015-05-15-P7D
50STUDYXQS23-P000150PT01035APT01-Bed/Pressure Sores PresencePRO-CTCAE V1.0CUTANEOUSNo00Y12015-05-15-P7D
51STUDYXQS23-P000151PT01036APT01-Radiation Skin Reaction SeverityPRO-CTCAE V1.0CUTANEOUSMild11Y12015-05-15-P7D
52STUDYXQS23-P000152PT01037APT01-Skin Darkening PresencePRO-CTCAE V1.0CUTANEOUSNo00Y12015-05-15-P7D
53STUDYXQS23-P000153PT01038APT01-Stretch Marks PresencePRO-CTCAE V1.0CUTANEOUSNo00Y12015-05-15-P7D
54STUDYXQS23-P000154PT01039APT01-Numbness & Tingling SeverityPRO-CTCAE V1.0NEUROLOGICALMild11Y12015-05-15-P7D
55STUDYXQS23-P000155PT01039BPT01-Numbness & Tingling InterferencePRO-CTCAE V1.0NEUROLOGICALSomewhat22Y12015-05-15-P7D
56STUDYXQS23-P000156PT01040APT01-Dizziness SeverityPRO-CTCAE V1.0NEUROLOGICALMild11Y12015-05-15-P7D
57STUDYXQS23-P000157PT01040BPT01-Dizziness InterferencePRO-CTCAE V1.0NEUROLOGICALSomewhat22Y12015-05-15-P7D
58STUDYXQS23-P000158PT01041APT01-Blurred Vision SeverityPRO-CTCAE V1.0VISUAL/PERCEPTUALMild11Y12015-05-15-P7D
59STUDYXQS23-P000159PT01041BPT01-Blurred Vision InterferencePRO-CTCAE V1.0VISUAL/PERCEPTUALSomewhat22Y12015-05-15-P7D
60STUDYXQS23-P000160PT01042APT01-Flashing Lights in Eyes PresencePRO-CTCAE V1.0VISUAL/PERCEPTUALNo00Y12015-05-15-P7D
61STUDYXQS23-P000161PT01043APT01-Visual Floaters PresencePRO-CTCAE V1.0VISUAL/PERCEPTUALNo00Y12015-05-15-P7D
62STUDYXQS23-P000162PT01044APT01-Watery Eyes SeverityPRO-CTCAE V1.0VISUAL/PERCEPTUALMild11Y12015-05-15-P7D
63STUDYXQS23-P000163PT01044BPT01-Watery Eyes InterferencePRO-CTCAE V1.0VISUAL/PERCEPTUALSomewhat22Y12015-05-15-P7D
64STUDYXQS23-P000164PT01045APT01-Ringing in Ears SeverityPRO-CTCAE V1.0VISUAL/PERCEPTUALMild11Y12015-05-15-P7D
65STUDYXQS23-P000165PT01046APT01-Concentration Problems SeverityPRO-CTCAE V1.0ATTENTION/MEMORYMild11Y12015-05-15-P7D
66STUDYXQS23-P000166PT01046BPT01-Concentration Problems InterferencePRO-CTCAE V1.0ATTENTION/MEMORYSomewhat22Y12015-05-15-P7D
67STUDYXQS23-P000167PT01047APT01-Memory Problems SeverityPRO-CTCAE V1.0ATTENTION/MEMORYMild11Y12015-05-15-P7D
68STUDYXQS23-P000168PT01047BPT01-Memory Problems InterferencePRO-CTCAE V1.0ATTENTION/MEMORYSomewhat22Y12015-05-15-P7D
69STUDYXQS23-P000169PT01048APT01-General Pain FrequencyPRO-CTCAE V1.0PAINOccasionally22Y12015-05-15-P7D
70STUDYXQS23-P000170PT01048BPT01-General Pain SeverityPRO-CTCAE V1.0PAINMild11Y12015-05-15-P7D
71STUDYXQS23-P000171PT01048CPT01-General Pain InterferencePRO-CTCAE V1.0PAINSomewhat22Y12015-05-15-P7D
72STUDYXQS23-P000172PT01049APT01-Headache FrequencyPRO-CTCAE V1.0PAINOccasionally22Y12015-05-15-P7D
73STUDYXQS23-P000173PT01049BPT01-Headache SeverityPRO-CTCAE V1.0PAINMild11Y12015-05-15-P7D
74STUDYXQS23-P000174PT01049CPT01-Headache InterferencePRO-CTCAE V1.0PAINSomewhat22Y12015-05-15-P7D
75STUDYXQS23-P000175PT01050APT01-Muscle Pain FrequencyPRO-CTCAE V1.0PAINOccasionally22Y12015-05-15-P7D
76STUDYXQS23-P000176PT01050BPT01-Muscle Pain SeverityPRO-CTCAE V1.0PAINMild11Y12015-05-15-P7D
77STUDYXQS23-P000177PT01050CPT01-Muscle Pain InterferencePRO-CTCAE V1.0PAINSomewhat22Y12015-05-15-P7D
78STUDYXQS23-P000178PT01051APT01-Joint Pain FrequencyPRO-CTCAE V1.0PAINOccasionally22Y12015-05-15-P7D
79STUDYXQS23-P000179PT01051BPT01-Joint Pain SeverityPRO-CTCAE V1.0PAINMild11Y12015-05-15-P7D
80STUDYXQS23-P000180PT01051CPT01-Joint Pain InterferencePRO-CTCAE V1.0PAINSomewhat22Y12015-05-15-P7D
81STUDYXQS23-P000181PT01052APT01-Insomnia SeverityPRO-CTCAE V1.0SLEEP/WAKEMild11Y12015-05-15-P7D
82STUDYXQS23-P000182PT01052BPT01-Insomnia InterferencePRO-CTCAE V1.0SLEEP/WAKESomewhat22Y12015-05-15-P7D
83STUDYXQS23-P000183PT01053APT01-Fatigue SeverityPRO-CTCAE V1.0SLEEP/WAKEMild11Y12015-05-15-P7D
84STUDYXQS23-P000184PT01053BPT01-Fatigue InterferencePRO-CTCAE V1.0SLEEP/WAKESomewhat22Y12015-05-15-P7D
85STUDYXQS23-P000185PT01054APT01-Anxious FrequencyPRO-CTCAE V1.0MOODOccasionally22Y12015-05-15-P7D
86STUDYXQS23-P000186PT01054BPT01-Anxious SeverityPRO-CTCAE V1.0MOODMild11Y12015-05-15-P7D
87STUDYXQS23-P000187PT01054CPT01-Anxious InterferencePRO-CTCAE V1.0MOODSomewhat22Y12015-05-15-P7D
88STUDYXQS23-P000188PT01055APT01-Discouraged FrequencyPRO-CTCAE V1.0MOODOccasionally22Y12015-05-15-P7D
89STUDYXQS23-P000189PT01055BPT01-Discouraged SeverityPRO-CTCAE V1.0MOODMild11Y12015-05-15-P7D
90STUDYXQS23-P000190PT01055CPT01-Discouraged InterferencePRO-CTCAE V1.0MOODSomewhat22Y12015-05-15-P7D
91STUDYXQS23-P000191PT01056APT01-Sad FrequencyPRO-CTCAE V1.0MOODOccasionally22Y12015-05-15-P7D
92STUDYXQS23-P000192PT01056BPT01-Sad SeverityPRO-CTCAE V1.0MOODMild11Y12015-05-15-P7D
93STUDYXQS23-P000193PT01056CPT01-Sad InterferencePRO-CTCAE V1.0MOODSomewhat22Y12015-05-15-P7D
94STUDYXQS23-P000194PT01057APT01-Irregular Menstrual Period PresencePRO-CTCAE V1.0GYNECOLOGIC/URINARYNo00Y12015-05-15-P7D
95STUDYXQS23-P000195PT01058APT01-Missed Menstrual Period PresencePRO-CTCAE V1.0GYNECOLOGIC/URINARYNo00Y12015-05-15-P7D
96STUDYXQS23-P000196PT01059APT01-Vaginal Discharge AmountPRO-CTCAE V1.0GYNECOLOGIC/URINARYSomewhat2
Y12015-05-15-P7D
97STUDYXQS23-P000197PT01060APT01-Vaginal Dryness SeverityPRO-CTCAE V1.0GYNECOLOGIC/URINARYMild11Y12015-05-15-P7D
98STUDYXQS23-P000198PT01061APT01-Painful Urination SeverityPRO-CTCAE V1.0GYNECOLOGIC/URINARYMild11Y12015-05-15-P7D
99STUDYXQS23-P000199PT01062APT01-Urinary Urgency FrequencyPRO-CTCAE V1.0GYNECOLOGIC/URINARYOccasionally22Y12015-05-15-P7D
100STUDYXQS23-P0001100PT01062BPT01-Urinary Urgency InterferencePRO-CTCAE V1.0GYNECOLOGIC/URINARYSomewhat22Y12015-05-15-P7D
191STUDYXQS23-P0001191PT01063APT01-Urinary Frequency FrequencyPRO-CTCAE V1.0GYNECOLOGIC/URINARYOccasionally22Y12015-05-15-P7D
102STUDYXQS23-P0001102PT01063BPT01-Urinary Frequency InterferencePRO-CTCAE V1.0GYNECOLOGIC/URINARYSomewhat22Y12015-05-15-P7D
103STUDYXQS23-P0001103PT01064APT01-Urine Color Change PresencePRO-CTCAE V1.0GYNECOLOGIC/URINARYNo00Y12015-05-15-P7D
104STUDYXQS23-P0001104PT01065APT01-Urinary Incontinence FrequencyPRO-CTCAE V1.0GYNECOLOGIC/URINARYOccasionally22Y12015-05-15-P7D
105STUDYXQS23-P0001105PT01065BPT01-Urinary Incontinence InterferencePRO-CTCAE V1.0GYNECOLOGIC/URINARYSomewhat22Y12015-05-15-P7D
106STUDYXQS23-P0001106PT01066APT01-Achieve&Maintain Erection SeverityPRO-CTCAE V1.0SEXUALMild11Y12015-05-15-P7D
107STUDYXQS23-P0001107PT01067APT01-Ejaculation FrequencyPRO-CTCAE V1.0SEXUALOccasionally22Y12015-05-15-P7D
108STUDYXQS23-P0001108PT01068APT01-Decreased Libido SeverityPRO-CTCAE V1.0SEXUALMild11Y12015-05-15-P7D
109STUDYXQS23-P0001109PT01069APT01-Delayed Orgasm PresencePRO-CTCAE V1.0SEXUALNo00Y12015-05-15-P7D
110STUDYXQS23-P0001110PT01070APT01-Unable to Have Orgasm PresencePRO-CTCAE V1.0SEXUALNo00Y12015-05-15-P7D
111STUDYXQS23-P0001111PT01071APT01-Pain w/Sexual Intercourse SeverityPRO-CTCAE V1.0SEXUALMild11Y12015-05-15-P7D
112STUDYXQS23-P0001112PT01072APT01-Breast Swelling&Tenderness SeverityPRO-CTCAE V1.0MISCELLANEOUSMild11Y12015-05-15-P7D
113STUDYXQS23-P0001113PT01073APT01-Bruising PresencePRO-CTCAE V1.0MISCELLANEOUSNo00Y12015-05-15-P7D
114STUDYXQS23-P0001114PT01074APT01-Chills FrequencyPRO-CTCAE V1.0MISCELLANEOUSOccasionally22Y12015-05-15-P7D
115STUDYXQS23-P0001115PT01074BPT01-Chills SeverityPRO-CTCAE V1.0MISCELLANEOUSMild11Y12015-05-15-P7D
116STUDYXQS23-P0001116PT01075APT01-Increased Sweating FrequencyPRO-CTCAE V1.0MISCELLANEOUSOccasionally22Y12015-05-15-P7D
117STUDYXQS23-P0001117PT01075BPT01-Increased Sweating SeverityPRO-CTCAE V1.0MISCELLANEOUSMild11Y12015-05-15-P7D
118STUDYXQS23-P0001118PT01076APT01-Decreased Sweating PresencePRO-CTCAE V1.0MISCELLANEOUSNo00Y12015-05-15-P7D
118STUDYXQS23-P0001118PT01077APT01-Hot Flashes FrequencyPRO-CTCAE V1.0MISCELLANEOUSOccasionally22Y12015-05-15-P7D
120STUDYXQS23-P0001120PT01077BPT01-Hot Flashes SeverityPRO-CTCAE V1.0MISCELLANEOUSMild11Y12015-05-15-P7D
121STUDYXQS23-P0001121PT01078APT01-Nosebleed FrequencyPRO-CTCAE V1.0MISCELLANEOUSOccasionally22Y12015-05-15-P7D
122STUDYXQS23-P0001122PT01078BPT01-Nosebleed SeverityPRO-CTCAE V1.0MISCELLANEOUSMild11Y12015-05-15-P7D
123STUDYXQS23-P0001123PT01079APT01-Pain&Swelling at Inj Site PresencePRO-CTCAE V1.0MISCELLANEOUSNo00Y12015-05-15-P7D
124STUDYXQS23-P0001124PT01080APT01-Body Odor SeverityPRO-CTCAE V1.0MISCELLANEOUSMild11Y12015-05-15-P7D
125STUDYXQS23-P0001125PT01081PT01-Any Other Symptoms ReportedPRO-CTCAE V1.0OTHER SYMPTOMSYes11Y12015-05-15-P7D
126STUDYXQS23-P0001126PT01082APT01-Other Symptom 1PRO-CTCAE V1.0OTHER SYMPTOMSAnother symptom 1Another symptom 1
Y12015-05-15-P7D
127STUDYXQS23-P0001127PT01082BPT01-Other Symptom 1 SeverityPRO-CTCAE V1.0OTHER SYMPTOMSMild11Y12015-05-15-P7D
128STUDYXQS23-P0001128PT01083APT01-Other Symptom 2PRO-CTCAE V1.0OTHER SYMPTOMSAnother symptom 2Another symptom 2
Y12015-05-15-P7D
129STUDYXQS23-P0001129PT01083BPT01-Other Symptom 2 SeverityPRO-CTCAE V1.0OTHER SYMPTOMSMild11Y12015-05-15-P7D
130STUDYXQS23-P0001130PT01084APT01-Other Symptom 3PRO-CTCAE V1.0OTHER SYMPTOMS


Y12015-05-15-P7D
131STUDYXQS23-P0001131PT01084BPT01-Other Symptom 3 SeverityPRO-CTCAE V1.0OTHER SYMPTOMS


Y12015-05-15-P7D
132STUDYXQS23-P0001132PT01085APT01-Other Symptom 4PRO-CTCAE V1.0OTHER SYMPTOMS


Y12015-05-15-P7D
133STUDYXQS23-P0001133PT01085BPT01-Other Symptom 4 SeverityPRO-CTCAE V1.0OTHER SYMPTOMS


Y12015-05-15-P7D
134STUDYXQS23-P0001134PT01086APT01-Other Symptom 5PRO-CTCAE V1.0OTHER SYMPTOMS


Y12015-05-15-P7D
135STUDYXQS23-P0001135PT01086BPT01-Other Symptom 5 SeverityPRO-CTCAE V1.0OTHER SYMPTOMS


Y12015-05-15-P7D
136STUDYXQS23-P0001136PT01087APT01-Other Symptom 6PRO-CTCAE V1.0OTHER SYMPTOMS


Y12015-05-15-P7D
137STUDYXQS23-P0001137PT01087BPT01-Other Symptom 6 SeverityPRO-CTCAE V1.0OTHER SYMPTOMS


Y12015-05-15-P7D
138STUDYXQS23-P0001138PT01088APT01-Other Symptom 7PRO-CTCAE V1.0OTHER SYMPTOMS


Y12015-05-15-P7D
139STUDYXQS23-P0001139PT01088BPT01-Other Symptom 7 SeverityPRO-CTCAE V1.0OTHER SYMPTOMS


Y12015-05-15-P7D
140STUDYXQS23-P0001140PT01089APT01-Other Symptom 8PRO-CTCAE V1.0OTHER SYMPTOMS


Y12015-05-15-P7D
141STUDYXQS23-P0001141PT01089BPT01-Other Symptom 8 SeverityPRO-CTCAE V1.0OTHER SYMPTOMS


Y12015-05-15-P7D
142STUDYXQS23-P0001142PT01090APT01-Other Symptom 9PRO-CTCAE V1.0OTHER SYMPTOMS


Y12015-05-15-P7D
143STUDYXQS23-P0001143PT01090BPT01-Other Symptom 9 SeverityPRO-CTCAE V1.0OTHER SYMPTOMS


Y12015-05-15-P7D
144STUDYXQS23-P0001144PT01091APT01-Other Symptom 10PRO-CTCAE V1.0OTHER SYMPTOMS


Y12015-05-15-P7D
145STUDYXQS23-P0001145PT01091BPT01-Other Symptom 10 SeverityPRO-CTCAE V1.0OTHER SYMPTOMS


Y12015-05-15-P7D



...